Hubei Jumpcan Pharmaceutical Co Ltd (600566) — Financial Flexibility Index
Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Financial Flexibility Index of -0.08x as of September 2025. Free cash flow of CN¥-212.62 Million (operating CF CN¥-243.75 Million minus capex CN¥31.12 Million) represents 0% of total liabilities (CN¥2.68 Billion). Check Hubei Jumpcan Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hubei Jumpcan Pharmaceutical Co Ltd Financial Flexibility Index (2000–2025)
Historical Financial Flexibility Index trend for Hubei Jumpcan Pharmaceutical Co Ltd across 26 annual periods. For the full cash flow conversion analysis, see Hubei Jumpcan Pharmaceutical Co Ltd cash conversion from operations.
Annual Financial Flexibility Index for Hubei Jumpcan Pharmaceutical Co Ltd (2000–2025)
Year-by-year free cash flow to debt coverage for Hubei Jumpcan Pharmaceutical Co Ltd. Explore 600566 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CN¥1.29 Billion | CN¥1.20 Billion | CN¥3.07 Billion | ▼ -33.0% |
| 2024 | 0.63x | CN¥2.35 Billion | CN¥2.18 Billion | CN¥3.73 Billion | ▼ -20.2% |
| 2023 | 0.79x | CN¥3.77 Billion | CN¥3.46 Billion | CN¥4.77 Billion | ▼ -0.1% |
| 2022 | 0.79x | CN¥2.86 Billion | CN¥2.62 Billion | CN¥3.63 Billion | ▲ +10.5% |
| 2021 | 0.71x | CN¥2.14 Billion | CN¥1.89 Billion | CN¥3.00 Billion | ▼ -11.1% |
| 2020 | 0.80x | CN¥2.21 Billion | CN¥1.78 Billion | CN¥2.75 Billion | ▼ -23.7% |
| 2019 | 1.05x | CN¥2.69 Billion | CN¥2.15 Billion | CN¥2.56 Billion | ▲ +3.6% |
| 2018 | 1.02x | CN¥2.38 Billion | CN¥1.71 Billion | CN¥2.34 Billion | ▲ +18.7% |
| 2017 | 0.86x | CN¥1.94 Billion | CN¥1.19 Billion | CN¥2.26 Billion | ▼ -10.0% |
| 2016 | 0.95x | CN¥1.24 Billion | CN¥913.10 Million | CN¥1.30 Billion | ▼ -20.3% |
| 2015 | 1.19x | CN¥1.04 Billion | CN¥645.48 Million | CN¥872.59 Million | ▲ +38.4% |
| 2014 | 0.86x | CN¥917.62 Million | CN¥616.11 Million | CN¥1.06 Billion | ▲ +33.4% |
| 2013 | 0.65x | CN¥557.27 Million | CN¥287.16 Million | CN¥862.04 Million | ▲ +352.8% |
| 2012 | 0.14x | CN¥71.68 Million | CN¥27.01 Million | CN¥502.07 Million | ▲ +1.6% |
| 2011 | 0.14x | CN¥61.15 Million | CN¥411.24K | CN¥435.00 Million | ▼ -62.2% |
| 2010 | 0.37x | CN¥127.63 Million | CN¥51.13 Million | CN¥342.89 Million | ▲ +894.3% |
| 2009 | 0.04x | CN¥12.11 Million | CN¥4.92 Million | CN¥323.37 Million | ▼ -61.4% |
| 2008 | 0.10x | CN¥31.39 Million | CN¥23.05 Million | CN¥323.43 Million | ▼ -33.9% |
| 2007 | 0.15x | CN¥44.55 Million | CN¥36.72 Million | CN¥303.49 Million | ▼ -21.3% |
| 2006 | 0.19x | CN¥56.07 Million | CN¥4.24 Million | CN¥300.69 Million | ▼ -61.9% |
| 2005 | 0.49x | CN¥123.18 Million | CN¥63.38 Million | CN¥251.96 Million | ▲ +302.5% |
| 2004 | 0.12x | CN¥27.21 Million | CN¥-37.74 Million | CN¥223.98 Million | ▼ -47.1% |
| 2003 | 0.23x | CN¥42.24 Million | CN¥2.24 Million | CN¥183.92 Million | ▼ -75.5% |
| 2002 | 0.94x | CN¥139.09 Million | CN¥22.00 Million | CN¥148.17 Million | ▲ +30.8% |
| 2001 | 0.72x | CN¥95.50 Million | CN¥7.43 Million | CN¥133.08 Million | ▲ +38.7% |
| 2000 | 0.52x | CN¥43.14 Million | CN¥23.73 Million | CN¥83.37 Million | — |